Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D de Valeriola

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant chemotherapy in 2005: standards and beyondM J Piccart, D de Valeriola, L Dal Lago, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1988
Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive daysP Dodion, D de Valeriola, N Crespeigne, et al.
British Journal of Cancer|May 5, 2005
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumoursA Awada, A Hendlisz, T Gil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basisE Tomiak, M J Piccart, J Kerger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1991
Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complexP F Dodion, D de Valeriola, N Crespeigne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of CancerA Hamilton, L Biganzoli, R Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumorsE Van Den Neste, D de Valeriola, J Kerger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedulesA Awada, S Giacchetti, B Gerard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2008
Need for global action for cancer controlP Boyle, B O Anderson, L C Andersson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant chemotherapy in 2005: standards and beyondM J Piccart, D de Valeriola, L Dal Lago, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1988
Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive daysP Dodion, D de Valeriola, N Crespeigne, et al.
British Journal of Cancer|May 5, 2005
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumoursA Awada, A Hendlisz, T Gil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basisE Tomiak, M J Piccart, J Kerger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1991
Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complexP F Dodion, D de Valeriola, N Crespeigne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of CancerA Hamilton, L Biganzoli, R Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumorsE Van Den Neste, D de Valeriola, J Kerger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedulesA Awada, S Giacchetti, B Gerard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2008
Need for global action for cancer controlP Boyle, B O Anderson, L C Andersson, et al.
Pageof 2